Carlsmed, Inc. says its CFO Leo Greenstein is leaving, and Richard Heppenstall will take over on September 28, 2026.

Sep 30, 2026, 9:21 AM ETNew bossRead the original at SEC EDGAR

Neutral

Carlsmed replaced its CFO with an experienced medical-device finance executive, and the filing says he left without a dispute over accounting or management. Severance, early share vesting, and the new CFO's $1,400,000 option award add costs, but some other unvested shares were forfeited.

CARL · Carlsmed, Inc.

AI read · Neutral

The AI's read

The handoff brings uncertainty, but the filing says the departure involved no dispute over accounting, reports, or controls. The new CFO has held senior finance jobs at medical-device companies, which supports continuity. Carlsmed owes the former CFO $500,000 in salary payments and $60,000 for advisory work. Some of his shares vest sooner, and the new CFO received stock options valued at $1,400,000. Other unvested awards were forfeited, leaving the disclosed facts mixed.

Get alerts for CARL

Follow Carlsmed, Inc. (CARL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CARL

Free on the App Store and Google Play, or on the web.